Edition 2024 of the Asociación Española de Hematología y Hemoterapia (SEHH) and the Sociedad Española de Trombosis y Hemostasia (SETH):
- Oral presentation on extended results from the Early Access Program (EAP) for aGvHD patients treated with MaaT013
- Poster on the Phoebus study: Phase 2b trial for patients receiving allo-GCSH
